Abingdon Health Plc (LON:ABDX – Get Free Report) reached a new 52-week high on Wednesday . The stock traded as high as GBX 8.50 and last traded at GBX 8.27, with a volume of 376584 shares changing hands. The stock had previously closed at GBX 7.75.
Abingdon Health Stock Performance
The company has a market capitalization of £20.76 million, a P/E ratio of -8.89 and a beta of 0.20. The business has a 50-day moving average of GBX 6.42 and a 200-day moving average of GBX 6.38. The company has a debt-to-equity ratio of 19.40, a current ratio of 1.76 and a quick ratio of 1.96.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Further Reading
- Five stocks we like better than Abingdon Health
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
